Bavarian Nordic A/S partnered with the Serum Institute of India to produce its mpox vaccine. The Serum Institute will supply the Indian market and expand Bavarian's global manufacturing capacity through a profit-sharing agreement. This comes as mpox cases surge, predominantly in the Democratic Republic of Congo, with a mutated strain spreading globally.
